Ozkan, G. Et Al. 2013. Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, no.2 , 134-140.

Ozkan, G., ULUSOY, Ş., SÖNMEZ, M., KARAHAN, S. C., MENTEŞE, A., Kaynar, K., ... BEKTAŞ, Ö.(2013). Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, no.2, 134-140.

Ozkan, Gulsum Et Al. "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels," CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, no.2, 134-140, 2013

Ozkan, Gulsum Et Al. "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, no.2, pp.134-140, 2013

Ozkan, G. Et Al. (2013) . "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, no.2, pp.134-140.

@article{article, author={Gulsum Ozkan Et Al. }, title={Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels}, journal={CLINICAL AND EXPERIMENTAL HYPERTENSION}, year=2013, pages={134-140} }